{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:11:42Z","timestamp":1790662302516,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.carrev.2026.02.012","type":"journal-article","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T16:25:48Z","timestamp":1771950348000},"page":"92-97","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Indications, contraindications, and usefulness of acetylcholine testing"],"prefix":"10.1016","volume":"88","author":[{"given":"Fardeen","family":"Faiz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivani","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sierra","family":"Fleming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Toleva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.carrev.2026.02.012_bb0005","series-title":"The ESC Handbook on Cardiovascular Pharmacotherapy","article-title":"Coronary artery spasm and microvascular angina","author":"Ong","year":"2019"},{"issue":"10","key":"10.1016\/j.carrev.2026.02.012_bb0010","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1056\/NEJMoa0907272","article-title":"Low diagnostic yield of elective coronary angiography","volume":"362","author":"Patel","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2026.02.012_bb0015","series-title":"Vessel Plus","article-title":"Contemporary pharmacological treatment strategies for patients with angina and unobstructed coronary arteries (ANOCA) due to coronary microvascular dysfunction","author":"McChord","year":"2021"},{"issue":"36","key":"10.1016\/j.carrev.2026.02.012_bb0020","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1093\/eurheartj\/ehae177","article-title":"2024 ESC Guidelines for the management of chronic coronary syndromes","volume":"45","author":"Vrints","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carrev.2026.02.012_bb0025","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1161\/CIR.0000000000000670","article-title":"Contemporary diagnosis and management of patients with myocardial infarction in the absence of obstructive coronary artery disease: a scientific statement from the American Heart Association","volume":"139","author":"Tamis-Holland","year":"2019","journal-title":"Circulation"},{"issue":"23_suppl_1","key":"10.1016\/j.carrev.2026.02.012_bb0030","doi-asserted-by":"crossref","first-page":"III-27","DOI":"10.1161\/01.CIR.0000131515.03336.f8","article-title":"Role of endothelial dysfunction in atherosclerosis","volume":"109","author":"Davignon","year":"2004","journal-title":"Circulation"},{"issue":"41","key":"10.1016\/j.carrev.2026.02.012_bb0035","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1093\/eurheartj\/eht351","article-title":"Endothelial dysfunction over the course of coronary artery disease","volume":"34","author":"Guti\u00e9rrez","year":"2013","journal-title":"Eur Heart J"},{"issue":"Suppl 1","key":"10.1016\/j.carrev.2026.02.012_bb0040","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2165\/1153642-S0-000000000-00000","article-title":"Coronary vasospasm: is it a myth?","volume":"10","author":"Sechtem","year":"2010","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.carrev.2026.02.012_bb0045","article-title":"Haemodynamic characterisation of different endotypes in coronary artery vasospasm in reaction to acetylcholine","volume":"42","author":"Feenstra","year":"2022","journal-title":"Int J Cardiol Heart Vasc"},{"key":"10.1016\/j.carrev.2026.02.012_bb0050","doi-asserted-by":"crossref","DOI":"10.15420\/usc.2022.33","article-title":"Invasive evaluation for coronary vasospasm","volume":"17","author":"Huang","year":"2023","journal-title":"US Cardiol"},{"issue":"17","key":"10.1016\/j.carrev.2026.02.012_bb0055","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1161\/CIRCULATIONAHA.113.004096","article-title":"Clinical usefulness, angiographic characteristics, and safety evaluation of intracoronary acetylcholine provocation testing among 921 consecutive white patients with unobstructed coronary arteries","volume":"129","author":"Ong","year":"2014","journal-title":"Circulation"},{"issue":"33","key":"10.1016\/j.carrev.2026.02.012_bb0060","first-page":"2565","article-title":"International standardization of diagnostic criteria for vasospastic angina","volume":"38","author":"Beltrame","year":"2017","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.carrev.2026.02.012_bb0065","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.122.012568","article-title":"Coronary microvascular disease in contemporary clinical practice","volume":"16","author":"Smilowitz","year":"2023","journal-title":"Circ Cardiovasc Interv"},{"issue":"6","key":"10.1016\/j.carrev.2026.02.012_bb0070","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.jcin.2012.01.023","article-title":"Safety of coronary reactivity testing in women with no obstructive coronary artery disease: results from the NHLBI-sponsored WISE (Women\u2019s Ischemia Syndrome Evaluation) study","volume":"5","author":"Wei","year":"2012","journal-title":"J Am Coll Cardiol Interv"},{"issue":"10","key":"10.1016\/j.carrev.2026.02.012_bb0075","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1093\/eurheartj\/ehx721","article-title":"Coronary microvascular dysfunction and future risk of heart failure with pretolserved ejection fraction","volume":"39","author":"Taqueti","year":"2018","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.carrev.2026.02.012_bb0080","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/eurheartj\/ehs199","article-title":"Clinical implications of provocation tests for coronary artery spasm: safety, arrhythmic complications, and prognostic impact: multicentre registry study of the Japanese Coronary Spasm Association","volume":"34","author":"Takagi","year":"2013","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.carrev.2026.02.012_bb0090","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jjcc.2016.09.012","article-title":"Overview of the pharmacological spasm provocation test: comparisons between acetylcholine and ergonovine","volume":"69","author":"Sueda","year":"2017","journal-title":"J Cardiol"},{"issue":"23 Part A","key":"10.1016\/j.carrev.2026.02.012_bb0110","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1016\/j.jacc.2018.09.006","article-title":"Stratified medical therapy using invasive coronary function testing in angina: the CorMicA trial","volume":"72","author":"Ford","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.carrev.2026.02.012_bb0115","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.3390\/jcm11041129","article-title":"Acetylcholine use in modern cardiac catheterization laboratories: a systematic review","volume":"11","author":"Marrone","year":"2022","journal-title":"J Clin Med"},{"issue":"3","key":"10.1016\/j.carrev.2026.02.012_bb0120","first-page":"292","article-title":"Coronary spasm testing with acetylcholine: a powerful tool for a personalized therapy of coronary vasomotor disorders","volume":"14","author":"Gurgoglione","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.carrev.2026.02.012_bb0125","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.723542","article-title":"Doppler echocardiography assessment of coronary microvascular function in patients with angina and no obstructive coronary artery disease","volume":"8","author":"Schroder","year":"2021","journal-title":"Front Cardiovasc Med"},{"issue":"4","key":"10.1016\/j.carrev.2026.02.012_bb0130","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1093\/cvr\/cvaa035","article-title":"Coronary microvascular disease: the next frontier for cardiovascular research","volume":"116","author":"Berry","year":"2020","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.carrev.2026.02.012_bb0135","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ijcard.2017.05.109","article-title":"Safety of intracoronary provocative testing for the diagnosis of coronary artery spasm","volume":"244","author":"Ciliberti","year":"2017","journal-title":"Int J Cardiol"},{"issue":"24","key":"10.1016\/j.carrev.2026.02.012_bb0140","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1016\/j.jacc.2022.03.385","article-title":"Safety of provocative testing with intracoronary acetylcholine and implications for standard protocols","volume":"79","author":"Takahashi","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2026.02.012_bb0145","series-title":"Presented at: Transcatheter Cardiovascular Therapeutics (396798063TCT-803)","article-title":"Diagnostic yield and safety of acetylcholine vasoreactivity testing in patients with ischemia and non-obstructive coronary arteries: insights from the DISCOVER-INOCA multicenter registry","author":"Shah","year":"2025"},{"issue":"5","key":"10.1016\/j.carrev.2026.02.012_bb0150","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1093\/eurheartj\/ehaf839","article-title":"Endotypes of angina with non-obstructive coronary arteries: a prospective multicenter study","volume":"47","author":"Miner","year":"2025","journal-title":"Eur Heart J"},{"issue":"12","key":"10.1016\/j.carrev.2026.02.012_bb0155","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.jacc.2023.06.043","article-title":"Comprehensive management of ANOCA, part 1-definition, patient population, and diagnosis: JACC state-of-the-art review","volume":"82","author":"Samuels","year":"2023","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.carrev.2026.02.012_bb0160","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/j.jacc.2023.06.044","article-title":"Comprehensive management of ANOCA, part 2-program development, treatment, and research initiatives: JACC state-of-the-art review","volume":"82","author":"Smilowitz","year":"2023","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.carrev.2026.02.012_bb0165","doi-asserted-by":"crossref","DOI":"10.4244\/EIJ-D-21-00971","article-title":"Safety and prognostic relevance of acetylcholine testing in patients with stable myocardial ischaemia or myocardial infarction and non-obstructive coronary arteries","volume":"18","author":"Montone","year":"2022","journal-title":"EuroIntervention"}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838926000576?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838926000576?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T19:48:37Z","timestamp":1783367317000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553838926000576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":29,"alternative-id":["S1553838926000576"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2026.02.012","relation":{},"ISSN":["1553-8389"],"issn-type":[{"value":"1553-8389","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Indications, contraindications, and usefulness of acetylcholine testing","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2026.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}